C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 259/06 (2006.01) A61K 31/16 (2006.01) A61K 31/33 (2006.01) C07C 323/41 (2006.01) C07D 207/27 (2006.01) C07D 213/56 (2006.01) C07D 225/02 (2006.01) C07D 231/12 (2006.01) C07D 233/61 (2006.01) C07D 277/30 (2006.01) C07D 333/24 (2006.01) C07D 333/60 (2006.01) C07D 521/00 (2006.01)
Patent
CA 2140626
Compounds of formula (I) have matrix metalloproteinase inhibitory activity, wherein R2 represents a group R6-A- wher- ein A represents a divalent straight or branched, saturated or unsaturated hydrocarbon chain of up to 6 C atoms which may be interrupted by an O or S atom, and R6 represents hydrogen or an optionally substituted phenyl, cycloalkyl or cycloalke- nyl group; R3 represents a group R7-(B)n- wherein n is 0 or 1, B represents a divalent straight or branched, saturated or un- saturated hydrocarbon chain of up to 6 C atoms which may be interrupted by an O or S atom, and R7 is -CONHOH, car- boxyl, esterified or amidated carboxyl, cycloalkyl, cycloalkenyl, heterocyclyl, phenyl, naphtyl, or substituted phenyl or naphtyl in which the substituent(s) are selected from phenyl, hydroxy, C1-C6 alkoxy, benzyloxy, or R8-(C=O)-(C1-C6al- kyl)-O- wherein R8 is hydroxy, amino, or an amino acid residue linked via an amide bond; or (except when n=0) R7 is hy- drogen; R4 represents hydrogen or methyl; R5 represents hydrogen, C1-C6 alkyl or a group D-(C1-C6 alkyl) wherein D re- presents hydroxy, (C1-C6)alkoxy, (C1-C6)alkylthio, acylamino, optionally substituted phenyl, or a heterocyclic group, NH2, or a mono- or di-(C1-NC6 alkyl) amine or a heterocyclic group; or R3 and R5 taken together represent a divalent, saturated or unsaturated hydrocarbon chain of from 8-14 C atoms, which may be interrupted by an O, S or N heteroatom, or a salt, solvate or hydrate thereof, provided that R3 is not the characteristic side chain of a natural alpha-amino acid, or the charac- teristic side chain of a natural alpha-amino acid in which any functional substituents are protected, any amino groups are acylated, and any carboxyl groups are esterified.
Beckett Raymond Paul
Crimmin Michael John
Dickens Jonathan Philip
British Biotech Pharmaceuticals Limited
Gowling Lafleur Henderson Llp
LandOfFree
Hydroxamic acid derivatives as metalloproteinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamic acid derivatives as metalloproteinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamic acid derivatives as metalloproteinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1465378